True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis
about
Perfusion magnetic resonance imaging: a comprehensive update on principles and techniquesImproving tumour heterogeneity MRI assessment with histograms.Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsDoes the Reporting Quality of Diagnostic Test Accuracy Studies, as Defined by STARD 2015, Affect Citation?Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitorPrognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaginPhysiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastomaMR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.Current Clinical Brain Tumor ImagingDynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort.Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysisExtended T2-IVIM model for correction of TE dependence of pseudo-diffusion volume fraction in clinical diffusion-weighted magnetic resonance imaging.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Selection and Reporting of Statistical Methods to Assess Reliability of a Diagnostic Test: Conformity to Recommended Methods in a Peer-Reviewed Journal.Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and TemozolomiDiffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors.Comparison of Contrast-Enhanced CT and [18F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer.Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomas.Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value.The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses.Pseudoprogression of CNS metastatic disease of alveolar soft part sarcoma during anti-PDL1 treatment☆☆☆.
P2860
Q27012911-3B8B3308-6B45-4413-8D0D-6C5A9D3F5A28Q27693208-9D9C9F7D-5F4E-4EDD-B24A-D2D672BEB6F9Q28066044-B0042F96-6143-4BC1-8E01-AA2A866754CDQ30375399-50710DE5-8F5C-4648-87D1-6697874BF520Q30838169-786FB53A-2EE0-44E7-9D2A-EA8CC876F1ECQ30871297-71FF8C2A-4C44-45DF-B8D8-4B3D02ACDFC9Q35771783-8C1645C5-9257-4A12-9E34-D818C0A8F7AAQ35815295-AF01126F-C430-4145-9CCC-4C1625B9FB6DQ36097886-C482F14A-FA47-4CF7-9B05-32E220F972E4Q36279879-2E56A3D2-8C34-4DB6-826F-28B840457E0EQ36324977-EEA258AC-4EFE-42BF-971E-DB34B28DDE7CQ36361484-90F5E77A-CE2D-4A31-852C-29BA4BC4CEA3Q36367172-A338EAF2-1E86-4669-A460-9066B44527EEQ36501577-C4E5F036-A583-49EE-B297-01CFAF84C4E6Q37064197-9F909168-0C71-46E1-92A5-18B3B07060F9Q37452768-46301806-F7EE-477D-98DA-840BAD88AE26Q38884741-45589C67-DA42-4BD8-9DE9-E81EFCF5DD28Q39148690-8FD2C70E-3FCF-430B-BE26-8002CC9BADD5Q39312420-D8B059E8-0356-4965-8E89-83235D0EE878Q42702576-9F960418-18A4-4D70-845A-A9299A7350ABQ47298392-7160BEE8-C46A-47C4-95FE-2E9D995D11F3Q47406548-54A869B9-2FC0-488D-A9F6-1AD845101859Q47437270-86322C23-BDE3-446E-825E-370C3EDCA2CFQ47963549-D125CF57-C5F0-4262-A923-FC13FF788E71Q48155295-53BD5F28-6A48-41FC-BB93-264EB1FFBA9BQ48156414-E2992FBA-A1F8-428C-844D-DE2B8171BF8EQ48519926-5916D8E3-AAC8-484E-A127-07FE5A62FF16Q48906044-9C8E62F9-83A4-4C72-9707-562DE99F7E61Q48930260-9220BA78-D2EC-4A42-8740-C6E71EF0B7C4Q49274965-2BD4D6E8-A04F-4D32-ACB1-786B6ABD6CDAQ51800219-420D1252-99B6-47C2-8F71-0C227A3CB383Q55031914-075F827D-CFA1-4391-8995-E5866C0179C2Q55516526-110E1646-23B6-4CF4-BE01-DE6E8EE51253
P2860
True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
True progression versus pseudo ...... fficient by histogram analysis
@en
True progression versus pseudo ...... ficient by histogram analysis.
@nl
type
label
True progression versus pseudo ...... fficient by histogram analysis
@en
True progression versus pseudo ...... ficient by histogram analysis.
@nl
prefLabel
True progression versus pseudo ...... fficient by histogram analysis
@en
True progression versus pseudo ...... ficient by histogram analysis.
@nl
P2093
P2860
P1476
True progression versus pseudo ...... fficient by histogram analysis
@en
P2093
Chul-Ho Sohn
Chul-Kee Park
Geon-Ho Jahng
Il Han Kim
Ji-Hoon Kim
Kee-Hyun Chang
Kyung Sik Yi
Se-Hoon Lee
Sung-Hye Park
Tae Min Kim
P2860
P304
P356
10.3348/KJR.2013.14.4.662
P577
2013-07-17T00:00:00Z